The store will not work correctly when cookies are disabled.
1-(3-Fluoro-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-hydroxymethyl-1H-pyrimidine-2,4-dione
ID: ALA2368768
PubChem CID: 3007909
Max Phase: Preclinical
Molecular Formula: C10H13FN2O6
Molecular Weight: 276.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2F)cc1CO
Standard InChI: InChI=1S/C10H13FN2O6/c11-6-7(16)5(3-15)19-9(6)13-1-4(2-14)8(17)12-10(13)18/h1,5-7,9,14-16H,2-3H2,(H,12,17,18)/t5-,6+,7-,9-/m1/s1
Standard InChI Key: QQGGRUHEDAEEQQ-JVZYCSMKSA-N
Molfile:
RDKit 2D
19 20 0 0 1 0 0 0 0 0999 V2000
8.9669 -1.4594 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9669 -2.2844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6814 -1.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6814 -0.2219 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2525 -1.0469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6344 -2.7693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2995 -2.7693 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2525 -0.2219 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9669 0.1906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3794 -3.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5544 -3.5539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3959 -1.4594 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9669 1.0156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4190 -2.5144 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.8644 -4.2214 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5380 0.1906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0695 -4.2214 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5380 1.0156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4051 -4.9750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
3 1 1 0
4 3 1 0
5 1 1 0
2 6 1 0
7 2 1 0
8 5 2 0
9 8 1 0
10 6 1 0
11 7 1 0
12 3 2 0
13 9 2 0
6 14 1 1
10 15 1 6
16 8 1 0
11 17 1 1
18 16 1 0
19 17 1 0
4 9 1 0
11 10 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 276.22 | Molecular Weight (Monoisotopic): 276.0758 | AlogP: -2.38 | #Rotatable Bonds: 3 |
Polar Surface Area: 124.78 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.74 | CX Basic pKa: ┄ | CX LogP: -2.41 | CX LogD: -2.41 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.49 | Np Likeness Score: 0.72 |
References
1. Matulic-Adamic J, Takahashi K, Chou TC, Gadler H, Price RW, Reddy AR, Kalman TI, Watanabe KA.. (1988) Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil., 31 (8): [PMID:2840503] [10.1021/jm00403a026] |